This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Bcl6 Sets a Threshold for Antiviral Signaling by Restraining IRF7 Transcriptional Program
Scientific Reports Open Access 05 January 2016
-
Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age
Scientific Reports Open Access 23 July 2015
-
Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer
Journal of Experimental & Clinical Cancer Research Open Access 16 October 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Swerdlow SHCE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds). WHO Classification: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, 2008.
Perez-Rosado A, Artiga M, Vargiu P, Sanchez-Aguilera A, Alvarez-Barrientos A, Piris M . BCL6 represses NFkappaB activity in diffuse large B-cell lymphomas. J Pathol 2008; 214: 498–507.
Carbone A, Gaidano G, Gloghini A, Pastore C, Saglio G, Tirelli U et al. BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas: inverse relationship with Epstein-Barr virus-encoded latent membrane protein-1 expression. Am J Pathol 1997; 150: 155–165.
Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J et al. Identification of virus-encoded microRNAs. Science 2004; 304: 734–736.
Ferry JA . Burkitt's lymphoma: clinicopathologic features and differential diagnosis. Oncologist 2006; 11: 375–383.
Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A et al. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 2002; 17: 51–62.
Vasanwala FH, Kusam S, Toney LM, Dent AL . Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene. J Immunol 2002; 169: 1922–1929.
Keller SA, Hernandez-Hopkins D, Vider J, Ponomarev V, Hyjek E, Schattner EJ et al. NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo. Blood 2006; 107: 3295–3302.
Davis RE, Brown KD, Siebenlist U, Staudt LM . Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 2001; 194: 1861–1874.
Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E . The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 1995; 80: 389–399.
Cahir McFarland ED, Izumi KM, Mosialos G . Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB. Oncogene 1999; 18: 6959–6964.
Cahir-McFarland ED, Carter K, Rosenwald A, Giltnane JM, Henrickson SE, Staudt LM et al. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells. J Virol 2004; 78: 4108–4119.
Klapproth K, Sander S, Marinkovic D, Baumann B, Wirth T . The IKK2/NF-{appa}B pathway suppresses MYC-induced lymphomagenesis. Blood 2009; 114: 2448–2458.
Acknowledgements
We would like to acknowledge all members of CNIOs Lymphoma Group for their thoughtful discussion. This study was funded with the following grants: from Ministerio de Educación y Ciencia, Spain SAF2007-65957-C02-02, SAF2008-03871; from the Fondo de Investigaciones Sanitarias, RTICC RD06/0020/0107 and PI10/00621; from Fundación Científica de la Asociación Española Contra el Cáncer (AECC). LDL is supported by a fellowship from Ministerio de Sanidad y Consumo (FI08/00038); NM is supported by a contract from Ministerio de Sanidad y Consumo (CP06/00002).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Leukemia website
Rights and permissions
About this article
Cite this article
Martín-Pérez, D., Vargiu, P., Montes-Moreno, S. et al. Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma. Leukemia 26, 180–183 (2012). https://doi.org/10.1038/leu.2011.189
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2011.189
This article is cited by
-
A review on EBV encoded and EBV-induced host microRNAs expression profile in different lymphoma types
Molecular Biology Reports (2021)
-
Bcl6 Sets a Threshold for Antiviral Signaling by Restraining IRF7 Transcriptional Program
Scientific Reports (2016)
-
Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age
Scientific Reports (2015)
-
Mutual interaction between BCL6 and miRNAs contributing to the pathogenesis of various cancers
Clinical and Translational Oncology (2015)
-
Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer
Journal of Experimental & Clinical Cancer Research (2013)